INGENIA Therapeutics

Private

Watertown, MassachusettsHealthcare & Life Scienceshttps://ingeniatx.com/

Last Round

Series B

Jun 21, 2024

Total Funding Raised

$20.9M

Company Overview

INGENIA Therapeutics is a biotechnology company that develops therapeutic antibodies to restore dysfunctional microvessels for application in ophthalmic and systemic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologytherapeutic antibodiesdrug developmentbispecific antibodyTIE2 pathwayvascular diseasedrug discoverybiologicsantibody engineeringretinal diseasesclinical-stage biotechlicensing agreementsvascular integritypharma pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

INGENIA Therapeutics Comparables

Compare INGENIA Therapeutics with similar companies based on industry and business-model similarity.

INGENIA Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
MabTics Co., Ltd.	89%
Memento Medicines	88%
AffaMed Therapeutics	86%

View all Comparables

INGENIA Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jun 21, 2024
VC Round	Jun 21, 2024
Series A	Nov 1, 2022
Seed	Sep 29, 2020
Seed	Sep 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Sangyeul Han

CEO

Executive Team

INGENIA Therapeutics Investors

Notable investors and investment history

INGENIA Therapeutics investors
Investor	Rounds
InterVest	Series A, Seed

View all Investors

INGENIA Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

INGENIA Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about INGENIA Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts

Employee Range25

Year Founded2018

Last FundingJun 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.